Filing Details
- Accession Number:
- 0001144204-14-058325
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2014-09-29 15:23:09
- Reporting Period:
- 2014-08-25
- Filing Date:
- 2014-09-29
- Accepted Time:
- 2014-09-29 15:23:09
- Original Submission Date:
- 2014-08-26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1117480 | Chimerix Inc | CMRX | Pharmaceutical Preparations (2834) | 330903395 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1571865 | W. Timothy Trost | C/O Chimerix, Inc. 2505 Meridian Parkway, Suite 340 Durham NC 27713 | Sr. Vice President And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-08-25 | 5,000 | $2.35 | 8,182 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-08-25 | 5,000 | $25.13 | 3,182 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2014-08-25 | 5,000 | $0.00 | 5,000 | $2.35 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 114,014 | 2021-04-06 | No | 4 | M | Direct |
Footnotes
- The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 5, 2013.
- This amendment has been prepared to amend the Amount of Securities Beneficially Owned Following Reported Transaction(s).
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.19 to $25.57 inclusive. The reporting person undertakes to provide to CMRX, any security holder of CMRX, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- In accordance with its terms, the shares underlying the option are subject to vesting as follows: 1/4th of the shares vest one year after July 26, 2010; the remainder of the shares vest in equal monthly installments thereafter over the next three years.
Billionaire Hedge Funds
